Clinical Trial: Misoprostol in Termination of First Trimester Missed Abortion

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Oral Versus Vaginal Misoprostol as Cervical Ripening Agent Prior to Surgical Termination of First Trimester Missed Abortions in Hawler Maternity Teaching Hospital in Erbil

Brief Summary: The purpose of this study is to determine whether oral versus vaginal misoprostol is effective in termination of first trimester missed abortion and to compare between two different routes.

Detailed Summary:

Objective: To compare the effectiveness of oral versus vaginal misoprostol prior to surgical termination of first trimester missed abortion as cervical priming agent , the difference of cervical dilatation immediately prior to operation , the duration of operation and side effects between two treatment groups.

Design: This study was conducted as randomised study.

Setting: Maternity Teaching Hospital in Hawler/ Kurdistan/ Iraq.

Population: Over a period of six months from the first of January to the thirtieth of June, 2008, one hundred women were included in this study. They were cases of first trimester abortion (6-12 weeks).

Method: Patients were randomly selected for the type of treatment they received. The first group (oral) were assigned to receive 400 micrograms of misoprostol orally as preoperative cervical priming agent, where as the second group (vaginal) were allocated to have treatment either with vaginal misoprostol to receive 400 micrograms vaginally.

Main outcome measure: Oral versus vaginal misoprostol as cervical ripening agent prior to termination of first trimester missed abortion.

Keywords: First trimester, missed abortion, misoprostol, cervical ripening, oral, vaginal.

Sponsor: Hawler Medical University

Current Primary Outcome: Priming with misoprostol administered orally or vaginally three hours before surgical termination of first trimester missed abortion under general anesthesia facilitates cervical dilatation [ Time Frame: 6 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Higher patient satisfaction for self administered oral misoprostol at home [ Time Frame: 6 months ]

Original Secondary Outcome: Same as current

Information By: Hawler Medical University

Dates:
Date Received: November 21, 2008
Date Started: January 2008
Date Completion:
Last Updated: November 24, 2008
Last Verified: November 2008